Merck GHIF

Merck GHIF, the Merck Global Health Innovation Fund, is the corporate venture arm of Merck. It backs digital health companies around the world, aiming to help them grow using the resources and healthcare expertise of its parent group.

What Merck GHIF offers

• Digital health investment — capital for platform companies with proven technologies or business models, with more than 60 investments made.
• Therapy planning — diagnostic and patient profiling tools, plus clinical decision support and care planning.
• Care management — care coordination, patient education and engagement, and population health monitoring.
• Health analytics and AI — turning large data sets into real-world evidence, with attention to data interoperability and security.
• eClinical trials — better site selection, patient recruitment and protocol adherence through analytics and mobile tools.
• Enabling technologies — tools for clinical operations, regulatory work, pharmacovigilance, supply chain, and sales and marketing.

Who it works with

The fund invests in healthcare technology companies, with a therapeutic emphasis on oncology, central nervous system disorders, immunology and virology. It also makes selective early-stage bets on emerging technologies.

Key facts

• Parent: Merck
• Investments: More than 60 in digital health
• Therapeutic focus: Oncology, CNS, immunology and virology